Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show

Tafenoquine, a prodrug that could fulfill the criteria for a mass eradication campaign.

Teprotumumab Improves Thyroid Eye Disease Across Phenotypes

NEW ORLEANS — Comparable improvements were observed with teprotumumab (Tepezza) between patients with age-related phenotypic I or II thyroid eye disease, according to results from

May 11, 2024

Helfie AI Partners with Microsoft to Expand Access to AI-Powered Health Assessments

What You Should Know: – Helfie AI, a global mobile health platform, has announced a strategic collaboration with Microsoft to offer its cutting-edge health assessment

October 31, 2024

Biopharma layoffs are leaving the industry’s scientists reeling — and in search of scarce opportunities

After getting laid off from Bristol Myers Squibb last December, Jennifer Ariazi is trying her best to be a Vulcan. Ariazi, a former BMS senior

July 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.